These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28169075)

  • 1. Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy.
    Wumkes ML; van der Velden AM; de Bruin E; Meerveld-Eggink A; Koopmans MP; Rimmelzwaan GF; Rijkers GT; Biesma DH
    Vaccine; 2017 Mar; 35(9):1299-1305. PubMed ID: 28169075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to influenza virus vaccination during chemotherapy in patients with breast cancer.
    Meerveld-Eggink A; de Weerdt O; van der Velden AMT; Los M; van der Velden AWG; Stouthard JML; Nijziel MR; Westerman M; Beeker A; van Beek R; Rimmelzwaan GF; Rijkers GT; Biesma DH
    Ann Oncol; 2011 Sep; 22(9):2031-2035. PubMed ID: 21303799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours.
    Wumkes ML; van der Velden AM; Los M; Leys MB; Beeker A; Nijziel MR; van der Velden AW; Westerman M; Meerveld-Eggink A; Rimmelzwaan GF; Rijkers GT; Biesma DH
    Vaccine; 2013 Dec; 31(52):6177-84. PubMed ID: 24176495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
    Hanitsch LG; Löbel M; Mieves JF; Bauer S; Babel N; Schweiger B; Wittke K; Grabowski P; Volk HD; Scheibenbogen C
    Vaccine; 2016 May; 34(21):2417-2423. PubMed ID: 27055021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccination in patients with breast cancer: a case-series analysis.
    Vilar-Compte D; Cornejo P; Valle-Salinas A; Roldán-Marin R; Iguala M; Cervantes Y; López I
    Med Sci Monit; 2006 Aug; 12(8):CR332-6. PubMed ID: 16865064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against influenza in patients with systemic sclerosis.
    Litinsky I; Balbir A; Zisman D; Mandelboim M; Mendelson E; Feld J; Braun Y; Anouk M; Kaufman I; Paran D; Caspi D; Elkayam O
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S7-11. PubMed ID: 22409886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S; Süss J; Oehring H; Schmidt J
    Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.
    Berglund A; Willén L; Grödeberg L; Skattum L; Hagberg H; Pauksens K
    Acta Oncol; 2014 Sep; 53(9):1212-20. PubMed ID: 24865118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
    Nabeshima S; Kashiwagi K; Murata M; Kanamoto Y; Furusyo N; Hayashi J
    J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
    Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy.
    Ottóffy G; Horváth P; Muth L; Sólyom A; Garami M; Kovács G; Nyári T; Molnár D; Pauler G; Jankovics I
    Pediatr Blood Cancer; 2014 Jun; 61(6):1013-6. PubMed ID: 24395342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio.
    Strindhall J; Ernerudh J; Mörner A; Waalen K; Löfgren S; Matussek A; Bengner M
    Infect Dis (Lond); 2016; 48(6):436-42. PubMed ID: 27030916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.
    Knuf M; Leroux-Roels G; Rümke HC; Abarca K; Rivera L; Lattanzi M; Pedotti P; Arora A; Kieninger-Baum D; Della Cioppa G
    Vaccine; 2015 Jan; 33(1):174-81. PubMed ID: 25444803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
    Adler S; Krivine A; Weix J; Rozenberg F; Launay O; Huesler J; Guillevin L; Villiger PM
    Rheumatology (Oxford); 2012 Apr; 51(4):695-700. PubMed ID: 22171015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
    Hui SL; Chu LW; Peiris JS; Chan KH; Chu D; Tsui W
    Vaccine; 2006 Jun; 24(25):5371-80. PubMed ID: 16713661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.
    Uno S; Kimachi K; Matsuo F; Miyazaki K; Oohama A; Kei J; Nishimura T; Odoh K; Kino Y
    Microbiol Immunol; 2012 Dec; 56(12):810-6. PubMed ID: 23009167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue.
    Prinsen H; van Laarhoven HW; Pots JM; Duiveman-de Boer T; Mulder SF; van Herpen CM; Jacobs JF; Leer JW; Bleijenberg G; Stelma FF; Torensma R; de Vries IJ
    Hum Vaccin Immunother; 2015; 11(7):1634-40. PubMed ID: 25996472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles.
    Keam B; Kim MK; Choi Y; Choi SJ; Choe PG; Lee KH; Kim TM; Kim TY; Oh DY; Kim DW; Im SA; Kim NJ; Heo DS; Park WB; Oh MD
    Cancer; 2017 Mar; 123(5):841-848. PubMed ID: 27997703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.